USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fiberlean Technologies Limited

USPTO PatentsView assignee record - 38 granted patents across 25 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: D21H (Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherw).

RSS updates for this company

The verdict

According to USPTO PatentsView, Fiberlean ranks #8,382 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 25 technology areas.

#8,382
of 49,997 US assignees by volume
Top 16%
by Innovation Score (49.0/100)
23.4
avg claims per patent
+160%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8382 · Foreign Corporation #8,382 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 38 grants
  • UPPER-Q #8,382/49,997
  • PHOTO-FINISH Endocyte
  • CPC-FOCUS D21H · 25 areas
  • INNOV-PAR 49.0/100
  • CLAIMS-DENSE 23.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +160% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Endocyte, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fiberlean’s 49.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Fiberlean

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Fiberlean's Innovation Score is 49.0/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Fiberlean?

Each dot is one of Fiberlean’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fiberlean’s own 23.4 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Fiberlean vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 37.938.038.03838.038.038.1 51015202530 Granted patents (volume) Avg claims / patent Endocyte, Inc. - 38, 15.11EndocyteExcelitas Technologies Corp. - 38, 17.45ExcelitasExpress Scripts, Inc. - 38, 10.34Express ScriptsFAR Eastern NEW Century Corporation - 38, 11.53FAR Eastern NEW C…Flexiv Ltd. - 38, 13.34FlexivFrazier Industrial Company - 38, 16.82Frazier IndustrialFonar Corporation - 38, 18.61FonarFoundation Medicine, Inc. - 38, 27.03Foundation Medici…Fiberlean Technologies Limited - 38, 23.45Fiberlean
Fiberlean vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fiberlean's grants concentrate

Fiberlean Technologies Limited is a focused PatentsView assignee: 25 CPC subclasses with 86.8% of grants classified under D21H (Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherw). Peak complete grant year is 2020 (7 grants) versus a trough of 2 in 2024. By volume, Fiberlean sits between Endocyte, Inc. and Foundation Medicine, Inc..

Fiberlean's three-year grant acceleration

Fiberlean Technologies Limited shows 13 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Fiberlean's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Fiberlean holds 38 patents at rank #8,382, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Fiberlean

By rank, the assignees closest to #8,382 in granted patent volume.

Leaders in D21H (Pulp Compositions)

Other assignees with the most granted patents in Fiberlean's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fiberlean, neither rank-band nor same-CPC leaders (those blocks stay above). In D21H (Pulp Compositions), Fiberlean ranks #18 of 361 assignees by patent count in that subclass.

Fiberlean's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20182019202020212022202320242025 2
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Fiberlean Technologies Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 4 10.5%
2019 6 15.8%
2020 7 18.4%
2021 6 15.8%
2022 5 13.2%
2023 6 15.8%
2024 2 5.3%
2025partial year 2 5.3%

Which technologies does Fiberlean Technologies Limited patent most?

Top 15 of 25 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Fiberlean Technologies Limited's patent record in context - here's where to go next.

  • Fiberlean Technologies Limited's lead technology class is D21H (Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherw), 86.8% of its portfolio - see every assignee active in that class. Explore D21H
  • Ranked #8,382 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Fiberlean Technologies Limited against Endocyte, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 49.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.